Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 7/20 | 0.60 |
| ▸ | NR1H3 | Q13133 | 7/20 | 0.60 |
| ▸ | PPARG | P37231 | 6/20 | 0.45 |
| ▸ | PPARA | Q07869 | 6/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2080791 | 0.90 | NR1H2 (0.73) | NR1H2NR1H3PPARGPPARA | |
| SCHEMBL1380740 | 0.89 | NR1H2 (0.64) | NR1H2NR1H3PPARGPPARAMAPT | |
| SCHEMBL1386176 | 0.87 | NR1H2 (0.71) | NR1H2NR1H3PPARGPPARACYP2C9 | |
| SCHEMBL1379075 | 0.84 | NR1H2 (0.65) | NR1H2NR1H3MAPT | |
| SCHEMBL1382860 | 0.83 | NR1H2 (0.77) | NR1H2NR1H3 | |
| SCHEMBL1379725 | 0.81 | NR1H2 (0.73) | NR1H2NR1H3MAPT | |
| SCHEMBL1382717 | 0.81 | NR1H2 (0.76) | NR1H2NR1H3 | |
| SCHEMBL1386493 | 0.80 | NR1H2 (0.75) | NR1H2NR1H3 | |
| SCHEMBL1379781 | 0.78 | NR1H2 (0.68) | NR1H2NR1H3PPARAMAPT | |
| SCHEMBL1383716 | 0.77 | NR1H2 (0.66) | NR1H2NR1H3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1763502-A1 | NOVEL HEXAFLUOROISOPROPANOL DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2007-03-21 | — | — | EP | disclosed |
| WO-2006000323-A1 | NOVEL HEXAFLUOROISOPROPANOL DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2006-01-05 | — | — | WO | disclosed |